DPLO stock forecast
Our latest prediction for Diplomat Pharmacy, Inc.'s stock price was made on the Oct. 2, 2019 when the stock price was at 4.76$.
In the short term (2weeks), DPLO's stock price should underperform the market by -0.26%. During that period the price should oscillate between -8.70% and +10.45%.
In the medium term (3months), DPLO's stock price should underperform the market by -0.01%. During that period the price should oscillate between -20.28% and +30.40%.Get email alerts
Create a solid portfolio with DPLO
About Diplomat Pharmacy, Inc.
Diplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates through the Specialty and Pharmacy Benefit Management segments. The Specialty segment offers a range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost specialty drugs, and a wide range of applications. The Pharmacy Benefit Management segment provides services designed to help the customers reduce the cost and manage the complexity of their prescription drug programs. The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI.
At the moment the company generates 5278M USD in revenues.
On its last earning announcement, the company reported a loss of -6.34$ per share.
The book value per share is 10.18$
Three months stock forecastOct. 2, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|